IL6 and neoplasm: They can ignite anti-tumor immune responses via expressing high levels of pro-inflammatory cytokines (tumor necrosis factor α, interleukin 1 [IL-1], IL-6, IL-12 or IL-23), major histocompatibility complex (MHC) molecules and inducible nitric oxide synthase.